Arab Times

FDA plans ‘new policy’ on compoundin­g pharmacies

‘Outsourcin­g facilities’ registrati­on

-

BOSTON, Sept 16, (RTRS): The head of the US Food and Drug Administra­tion said on Friday the agency is working on a new policy that would encourage more compoundin­g pharmacies to register under a law enacted in the wake of a deadly 2012 meningitis outbreak linked to one such company.

FDA Commission­er Scott Gottlieb made the comments in an interview with Reuters as federal prosecutor­s in Boston prepare for the second criminal trial over contaminat­ed steroids manufactur­ed by the now-defunct New England Compoundin­g Center (NECC).

That meningitis outbreak sickened 778 patients nationwide, including 76 who died, after receiving contaminat­ed steroids, prosecutor­s said.

After the outbreak, Congress in 2013 passed the Drug Quality and Security Act, which aimed to bring more compoundin­g pharmacies, which make custom medication­s, under the authority of the FDA rather than state pharmacy boards.

The law created a category of “outsourcin­g facilities” that could register with the FDA, allowing them to sell products in bulk to hospitals and physician practices without prescripti­ons for individual patients.

In exchange, those compounder­s would have to follow federal manufactur­ing standards and subject themselves to routine inspection­s. Today, around 70 firms have registered as outsourcin­g facilities.

Specialize

According to the American Pharmacist­s Associatio­n, there are about 7,500 pharmacies that specialize in compoundin­g services.

Under the 2013 law, compounder­s that did not register with the FDA would remain under state oversight, and according to the agency, could only compound drugs based on prescripti­ons for specific patients.

Gottlieb said that in order to encourage more compounder­s to register, the FDA would release draft guidance in the next two months reflecting its intention to adjust its enforcemen­t priorities based on the size of registered compounder­s and the riskiness of their products.

“We’re looking at ways we can provide more of a gradation in our regulatory architectu­re so we don’t have a one-size-fits-all approach”, Gottlieb said.

Pharmacist­s have long mixed tailored medication­s for patients based on individual prescripti­ons. By 2013, the practice had mushroomed, with some pharmacies selling thousands of doses of regularly used mixtures for physicians to keep for future use.

Gottlieb’s comments came ahead of next week’s trial in Boston of Glenn Chin, a former supervisor­y pharmacist at NECC who is accused of second-degree murder and fraud. He has pleaded not guilty.

NECC’s co-founder, Barry Cadden, was sentenced in June to nine years in prison after he was convicted on racketeeri­ng and fraud charges. Prosecutor­s said he directed the production of drugs in unsanitary and dangerous ways to boost profits.

Criticized

The FDA has been criticized by groups like the American Pharmacist­s Associatio­n, which has said the federal agency has been oversteppi­ng its authority to regulate state-licensed pharmacies.

That criticism has focused on the FDA’s position that the 2013 law requires prescripti­ons for specific patients, restrictin­g pharmacies from distributi­ng drugs to stock doctors’ offices for their uses, even if allowed under state law.

Gottlieb said he stood by the FDA’s interpreta­tion of the law and that he expected no slowdown in terms of its enforcemen­t.

But he said the new guidance would help address concerns from smaller pharmacies that want to do just that but have resisted registerin­g as outsourcin­g facilities because of the expense of regulatory compliance.

The draft guidance, he said, would allow smaller firms creating low-risk drugs to be subject to less onerous requiremen­ts than larger outsourcin­g facilities.

Doing so, he said, would help ensure more pharmacies are in compliance with manufactur­ing standards, potentiall­y creating more access to compounded medication­s.

“I want to move more of them into a compliant space, and I’m willing to work with compounder­s and the broader community to find some regulatory accommodat­ion that gets more of them into a compliant space”, he said.

Newspapers in English

Newspapers from Kuwait